Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-05

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's original application for dexmethylphenidate hydrochloride as a generic ADHD treatment, marking the first generic entry for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmethylphenidate hydrochloride (generic) (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)